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Heart Failure With
Normal Ejection Fraction
The Diagnostic Importance
of Left Atrial Volume
Heart failure with normal ejection fraction (HFNEF) is common
and causes considerable morbidity, but treatment options are
limited, and the pathophysiology of HFNEF remains incompletely
understood (1). A factor that has hampered research into HFNEF
has been the lack of a gold standard for noninvasive diagnosis.
Although echocardiography is very good at demonstrating normal
left ventricular ejection fraction, Doppler techniques for estimation
of diastolic function and left atrial (LA) pressure are less reliable
(2) and are complex (3). In contrast, calculation of LA volume is
a simple technique, and although not the gold standard for
HFNEF diagnosis, increased LA volume index is associated with
more severe abnormalities of diastolic function and is an indepen-
dent predictor for the development of congestive heart failure (4).
Furthermore, there is a biologically plausible explanation for the
diagnostic and prognostic significance of increased LA volume,
which is that LA remodeling occurs as a result of chronic elevation
of LA pressure. In dyspneic subjects with normal left ventricular
ejection fraction, the finding of LA dilation provides support that
the dyspnea is due to HFNEF. Conversely, the absence of LA
dilation in such individuals argues against a cardiac cause of
dyspnea even in the presence of Doppler abnormalities of diastolic
function (4). Such findings have resulted in increased recognition
of the importance of LA volume assessment in recent diastolic
function guidelines (3,5).
Given the importance of LA size and the ease of its assessment,
we believe it is vital for the interpretation of HFNEF that LA
volume is always reported. There is even a strong rationale why LA
dilation might be considered an eligibility criterion for studies ofHFNEF. However, that such an approach is not current practice
is evident in 2 recent studies with potential to provide valuable
insights into the factors that may predispose to exercise intolerance
in HFNEF (6,7). In a study from Borlaug et al. (6) of HFNEF
subjects selected based on Framingham criteria, LA size was not
reported at all. In a study from Maeder et al. (7) of subjects with
suspected HFNEF, LA volume index was in the normal range and
not significantly higher than controls. Although this finding was
not discussed by the authors, it raised 2 important possibilities for
the interpretation of the study: either the study group may have
included subjects who did not have HFNEF, or alternatively, there
is a subgroup of subjects with HFNEF who do not develop LA
dilation.
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Reply
We thank Dr. Mottram and colleagues for their interest in our
paper (1). We agree that left atrial volume is a useful diagnostic
marker of chronic heart failure with preserved ejection fraction
(HFpEF). In our study (1), mean left atrial volume was 45  13
l/m2 in HFpEF patients, 31  8 ml/m2 in hypertensive patients
p  0.001 vs. HFpEF), and 29  5 ml/m2 in controls (p  0.005
vs. HFpEF, p  0.5 vs. hypertensive patients). These values are
similar to or in excess of those reported in HFpEF patients in
previous studies (2,3), and are certainly consistent with the
diagnosis of chronic HFpEF in our cohort.
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Reply
We thank Dr. Mottram and colleagues for their interest in our
paper (1). In their correspondence, they highlight the current lack
of consensus over the noninvasive diagnosis of heart failure with
normal ejection fraction (HFNEF). We believe this dilemma
represents the combined result of ongoing debate about the
pathophysiology of HFNEF together with the fact that present
guidelines utilize only resting echocardiographic or hemodynamic
measurements (2), even though symptoms principally develop
during physical activity. In our cohort of HFNEF patients with
markedly reduced peak oxygen consumption, there was a rapid rise
in left ventricular (LV) filling pressure at low workload, consistent
with the hypothesis that the key abnormality in HFNEF is a steep
LV pressure-volume relationship (1,3,4). Of note, our patients had
a normal resting pulmonary capillary wedge pressure (PCWP)
similar to that reported by others (3), possibly due to the presence
of concomitant medication.
Dr. Mottram and colleagues suggest that left atrial (LA) volume
should be considered a key measurement in the diagnosis of
patients with possible HFNEF, and that it could even be used as
an eligibility criterion for entry into HFNEF studies. We believe
that reliance on such a structural discriminator is unwarranted.Clearly, LA enlargement develops progressively as a reflection of a
sustained increase in LV end-diastolic pressure, for example, in
patients with advanced HF due to systolic dysfunction. In our
study, resting PCWP was normal, providing a possible explanation
for the relatively normal LA size. Moreover, the use of inhibitors
of the renin-angiotensin-aldosterone axis is known to reduce LA
size in this patient group (5). Accordingly, we suggest that in some
HFNEF patients, there is only an episodic rather than chronic
increase in LA pressure, which is not sufficient for the induction of
LA dilation, thus limiting its utility in the diagnosis of HFNEF.
Taken together, we suggest that diagnostic utility of measure-
ments performed only at rest (particularly parameters that are
highly load-dependent) for the evaluation of the HFNEF patient
is limited. As a corollary, we further encourage the inclusion of
exercise hemodynamic measures into the diagnostic evaluation in
patients with possible HFNEF.
Micha T. Maeder, MD
*David M. Kaye, MD, PhD
*Heart Failure Research Group
Baker IDI Heart and Diabetes Institute
P.O. Box 6492 St. Kilda Road Central
Melbourne 8008 Victoria
Australia
E-mail: david.kaye@bakeridi.edu.au
doi:10.1016/j.jacc.2010.11.032
EFERENCES
1. Maeder MT, Thompson BR, Brunner-La Rocca HP, Kaye DM.
Hemodynamic basis of exercise limitation in patients with heart failure
and normal ejection fraction. J Am Coll Cardiol 2010;56:855–63.
2. Paulus WJ, Tschope C, Sanderson JE, et al. How to diagnose diastolic
heart failure: a consensus statement on the diagnosis of heart failure
with normal left ventricular ejection fraction by the Heart Failure and
Echocardiography Associations of the European Society of Cardiology.
Eur Heart J 2007;28:2539–50.
3. Borlaug BA, Nishimura RA, Sorajja P, Lam CS, Redfield MM.
Exercise hemodynamics enhance diagnosis of early heart failure with
preserved ejection fraction. Circ Heart Fail 2010;3:588–95.
4. Paulus WJ. Culprit mechanism(s) for exercise intolerance in heart
failure with normal ejection fraction. J Am Coll Cardiol 2010;56:
864–6.
5. Mottram PM, Haluska B, Leano R, Cowley D, Stowasser M, Marwick
TH. Effect of aldosterone antagonism on myocardial dysfunction in
hypertensive patients with diastolic heart failure. Circulation 2004;110:
558–65.
